Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $262,525 | 337 | 99.8% |
| Food and Beverage | $600.45 | 28 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $191,725 | 249 | $0 (2022) |
| CSL Plasma Inc. | $70,800 | 88 | $0 (2024) |
| Alkermes, Inc. | $148.38 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $117.85 | 6 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $94.07 | 6 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $82.40 | 4 | $0 (2023) |
| Indivior Inc. | $80.24 | 4 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.70 | 1 | $0 (2021) |
| Brainsway USA INC | $17.73 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $14.83 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,400 | 45 | CSL Plasma Inc. ($35,400) |
| 2023 | $35,476 | 46 | CSL Plasma Inc. ($35,400) |
| 2022 | $32,453 | 42 | CSL Behring ($32,350) |
| 2021 | $33,808 | 48 | CSL Behring ($33,775) |
| 2020 | $33,726 | 48 | CSL Behring ($33,650) |
| 2019 | $31,725 | 46 | CSL Behring ($31,600) |
| 2018 | $26,271 | 39 | CSL Behring ($26,200) |
| 2017 | $34,266 | 51 | CSL Behring ($34,150) |
All Payment Transactions
365 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/27/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 11/13/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 10/30/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 10/30/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 10/30/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 10/16/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 10/02/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| 10/02/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 09/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| 09/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| 08/28/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 08/21/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| 08/07/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| 07/31/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 07/24/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 07/17/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| 07/10/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 07/01/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| 06/24/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 06/24/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 06/12/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 06/12/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
About Dr. Robert Althar, MD
Dr. Robert Althar, MD is a Addiction Medicine healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487655155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Althar, MD has received a total of $263,125 in payments from pharmaceutical and medical device companies, with $35,400 received in 2024. These payments were reported across 365 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($262,525).
Practice Information
- Specialty Addiction Medicine
- Other Specialties Surgery of the Hand, General Practice
- Location Pensacola, FL
- Active Since 08/03/2005
- Last Updated 11/22/2022
- Taxonomy Code 2084A0401X
- Entity Type Individual
- NPI Number 1487655155
Products in Payments
- VIVITROL (Drug) $120.27
- INGREZZA (Drug) $82.40
- REXULTI (Drug) $80.70
- SUBLOCADE (Drug) $63.95
- INVEGA TRINZA (Drug) $63.10
- SPRAVATO (Drug) $35.71
- TRINTELLIX (Drug) $32.70
- Vivitrol (Drug) $28.11
- INVEGA SUSTENNA (Drug) $19.04
- Brainsway Deep TMS (Device) $17.73
- SUBOXONE SUBLINGUAL FILM (Drug) $16.29
- BELSOMRA (Drug) $14.83
- ABILIFY MAINTENA (Drug) $13.37
- Zubsolv (Drug) $12.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.